Product Information

METHYLPHENIDATE 10 MG/9 HR PATCH is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $5.9313 per EA under NDC 00378826093. Its NADAC has been published 162 times since Oct 18, 2023.

FDA first approved this application on Mar 14, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE 10 MG/9 HR PATCH

Methylphenidate
$5.9313per EA
DEA Schedule CII

Strength

1.1 mg/h

NDC

00378826093

Classification

Generic

Dosage Form

PATCH

Route

TRANSDERMAL

Effective Date

11/18/2026

Active Ingredients

METHYLPHENIDATE

Approval Type

Generic (ANDA)

FDA Application

ANDA206497

FDA Approved

3/14/2022

TE Code

AB

On Market Since

6/27/2022

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE 10 MG/9 HR PATCH has been published 162 times since Oct 18, 2023, and over the history we have for it it has declined 45.3%. The table below summarizes its recorded NADAC range and movement.

Current price$5.9313 per EA
All-time high$11.4748 (May 15, 2024)
All-time low$5.9313 (Nov 18, 2026)
52-week high$10.3223
52-week low$5.9313
Median price$9.2779
Average price$9.3147
Largest weekly change+9.1% (Nov 19, 2025)
Weeks tracked162
Tracking sinceOct 18, 2023

Price History

1W

-5.8%

1M

-11.0%

3M

-17.7%

6M

-32.6%

1Y

-41.6%

3Y

-45.3%

5Y

N/A

All

-45.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methylphenidate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE 10 MG/9 HR PATCH?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 10 MG/9 HR PATCH, manufactured by Mylan Pharmaceuticals Inc., is $5.9313 per EA (NDC 00378826093), effective Nov 18, 2026.

How has the price of METHYLPHENIDATE 10 MG/9 HR PATCH changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE 10 MG/9 HR PATCH has declined 45.3%. It has been tracked across 162 weekly CMS publications since Oct 18, 2023.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 10 MG/9 HR PATCH?

Since Oct 18, 2023, the NADAC for METHYLPHENIDATE 10 MG/9 HR PATCH has ranged from a low of $5.9313 (Nov 18, 2026) to a high of $11.4748 (May 15, 2024), with a median of $9.2779 per EA.

Are there cheaper alternatives to METHYLPHENIDATE 10 MG/9 HR PATCH?

No other NADAC-published product currently shares the active ingredient and strength of METHYLPHENIDATE 10 MG/9 HR PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures METHYLPHENIDATE 10 MG/9 HR PATCH?

METHYLPHENIDATE 10 MG/9 HR PATCH (NDC 00378826093) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.